Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking

Therapeutics: Helping vesicles to deliver drugs inside cells An increased understanding of how extracellular vesicles (EVs) enter cells and deliver molecules will enable promising new therapies, according to researchers in the Netherlands, UK and France. EVs are liquid-filled sacs secreted by cells...

Full description

Bibliographic Details
Main Authors: Daniel E. Murphy, Olivier G. de Jong, Maarten Brouwer, Matthew J. Wood, Grégory Lavieu, Raymond M. Schiffelers, Pieter Vader
Format: Article
Language:English
Published: Nature Publishing Group 2019-03-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-019-0223-5
id doaj-316df075eed04434ba364fbd33b3895c
record_format Article
spelling doaj-316df075eed04434ba364fbd33b3895c2020-12-08T13:49:25ZengNature Publishing GroupExperimental and Molecular Medicine1226-36132092-64132019-03-0151311210.1038/s12276-019-0223-5Extracellular vesicle-based therapeutics: natural versus engineered targeting and traffickingDaniel E. Murphy0Olivier G. de Jong1Maarten Brouwer2Matthew J. Wood3Grégory Lavieu4Raymond M. Schiffelers5Pieter Vader6Laboratory of Clinical Chemistry and Haematology, UMC UtrechtLaboratory of Clinical Chemistry and Haematology, UMC UtrechtLaboratory of Clinical Chemistry and Haematology, UMC UtrechtDepartment of Physiology, Anatomy and Genetics, University of OxfordInstitut Curie, PSL Research UniversityLaboratory of Clinical Chemistry and Haematology, UMC UtrechtLaboratory of Clinical Chemistry and Haematology, UMC UtrechtTherapeutics: Helping vesicles to deliver drugs inside cells An increased understanding of how extracellular vesicles (EVs) enter cells and deliver molecules will enable promising new therapies, according to researchers in the Netherlands, UK and France. EVs are liquid-filled sacs secreted by cells that transport proteins, lipids and RNA between cells, and therefore have potential for delivering drugs. Pieter Vader at UMC Utrecht and co-workers review recent research into EVs, focusing on how EVs are distributed around the body, and how they target and enter cells. However, there is little known about EV biology once they are inside cells, and it is likely that many EVs simply degrade without delivering their cargo. Further research in this area could help identify features that improve cargo escape from EVs, thus ensuring that future therapies can be effective.https://doi.org/10.1038/s12276-019-0223-5
collection DOAJ
language English
format Article
sources DOAJ
author Daniel E. Murphy
Olivier G. de Jong
Maarten Brouwer
Matthew J. Wood
Grégory Lavieu
Raymond M. Schiffelers
Pieter Vader
spellingShingle Daniel E. Murphy
Olivier G. de Jong
Maarten Brouwer
Matthew J. Wood
Grégory Lavieu
Raymond M. Schiffelers
Pieter Vader
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Experimental and Molecular Medicine
author_facet Daniel E. Murphy
Olivier G. de Jong
Maarten Brouwer
Matthew J. Wood
Grégory Lavieu
Raymond M. Schiffelers
Pieter Vader
author_sort Daniel E. Murphy
title Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
title_short Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
title_full Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
title_fullStr Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
title_full_unstemmed Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
title_sort extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
publisher Nature Publishing Group
series Experimental and Molecular Medicine
issn 1226-3613
2092-6413
publishDate 2019-03-01
description Therapeutics: Helping vesicles to deliver drugs inside cells An increased understanding of how extracellular vesicles (EVs) enter cells and deliver molecules will enable promising new therapies, according to researchers in the Netherlands, UK and France. EVs are liquid-filled sacs secreted by cells that transport proteins, lipids and RNA between cells, and therefore have potential for delivering drugs. Pieter Vader at UMC Utrecht and co-workers review recent research into EVs, focusing on how EVs are distributed around the body, and how they target and enter cells. However, there is little known about EV biology once they are inside cells, and it is likely that many EVs simply degrade without delivering their cargo. Further research in this area could help identify features that improve cargo escape from EVs, thus ensuring that future therapies can be effective.
url https://doi.org/10.1038/s12276-019-0223-5
work_keys_str_mv AT danielemurphy extracellularvesiclebasedtherapeuticsnaturalversusengineeredtargetingandtrafficking
AT oliviergdejong extracellularvesiclebasedtherapeuticsnaturalversusengineeredtargetingandtrafficking
AT maartenbrouwer extracellularvesiclebasedtherapeuticsnaturalversusengineeredtargetingandtrafficking
AT matthewjwood extracellularvesiclebasedtherapeuticsnaturalversusengineeredtargetingandtrafficking
AT gregorylavieu extracellularvesiclebasedtherapeuticsnaturalversusengineeredtargetingandtrafficking
AT raymondmschiffelers extracellularvesiclebasedtherapeuticsnaturalversusengineeredtargetingandtrafficking
AT pietervader extracellularvesiclebasedtherapeuticsnaturalversusengineeredtargetingandtrafficking
_version_ 1724389219808313344